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Abstract The effect of the green tea compounds 2-(3,4-
dihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3,5,7-triol (ca-
techin), epicathechin (EC), epigallocathechin-3 gallate (EGCG),
epicathechin-3 gallate (ECG) and catechin-3 gallate (CG) on the
tyrosine phosphorylation of PDGF L-receptor (PDGF-RL) and
on the anchorage-independent growth of A172 glioblastoma cells
in semisolid agar has been investigated. Treatment of A172
glioblastoma with 50 WM CG, ECG, EGCG and 25 WM
Tyrphostin 1296 resulted in an 82 þ 17%, 77 þ 21%, 75 þ 8% and
55 þ 11%, respectively (mean þ S.D., n = 3) inhibition of the
PDGF-BB-induced tyrosine phosphorylation of PDGF-RL. The
PDGF-RL downstream intracellular transduction pathway in-
cluding tyrosine phosphorylation of phospholipase C-Q1 (PLC-
Q1) and phosphatidylinositol 3P-kinase (PI 3P-K) was also
inhibited. Spheroid formation was completely inhibited by
50 WM ECG, CG, EGCG and by 25 WM Tyrphostin 1296. We
conclude that catechins of the green tea possessing the gallate
group in their chemical structure act as anticancer agents
probably partly via their ability to suppress the tyrosine kinase
activity of the PDGF-RL.
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1. Introduction
Several epidemiological studies suggest that black and
especially green tea consumption is associated with a reduced
risk of several forms of cancer in human populations [1,2].
Furthermore, there is evidence from experimental animal
studies that consumption of green tea inhibits several tumor
types [3^5]. Green tea consists mainly of catechins such as 2-
(3,4-dihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3,5,7-tri-
ol (catechin), epicathechin (EC), epigallocathechin-3 gallate
(EGCG), epicathechin-3 gallate (ECG) and catechin-3 gallate
(CG). In the last years, major attention has been focused on
the anticancer activity of the green tea compound EGCG. In
order to explain the anticancer activity of EGCG, di¡erent
mechanisms have been postulated, e.g. EGCG might inhibit
enzyme urokinase (uPA) activity, one of the most frequently
overexpressed enzymes in human cancers [6]. However, the
used e¡ective concentration of EGCG seems to be physiolog-
ically too high (1 to 10 mM) for anticancer prevention ob-
served by green tea [6]. More recently, it has been reported
that EGCG may prevent cancer by inhibition of angiogenesis
[7]. In this context, a remarkable suppression of the vascular
endothelial growth factor (VEGF)-induced vascularization by
oral green tea consumption in the mouse cornea has been
demonstrated. Also, EGCG e¡ectively inhibited the angiogen-
esis in the chick chorioallantoic membrane assay [7]. In an
attempt to o¡er a possible explanation for the anticancer ac-
tivity of EGCG, we recently demonstrated that colony forma-
tion of the sis-transfected NIH 3T3 cells and spheroid’s for-
mation of human glioblastoma cells (A172) in semisolid agar
were e¡ectively inhibited by 50 WM EGCG and Tyrphostin
1296 [8]. Tyrphostin 1296 is a selective inhibitor of the tyro-
sine phosphorylation of the PDGF-RL [9,10]. PDGF-BB
propagates mitogenic signals through autophosphorylation
of its PDGF-RL on tyrosine residues. Autophosphorylation
of PDGF-RL results in tyrosine phosphorylation of di¡erent
substrate proteins such as the phospholipase C-Q1 (PLC-Q1),
p21ras GTPase activating protein (GAP) and phosphatidylino-
sitol 3P-kinase (PI 3P-K) carrying Src homology region 2 (SH2)
domains that are capable of binding to speci¢c regions of the
phosphorylated PDGF-RL [11,12]. In addition, activation of
Ras occurs through binding of the adapter protein complex
Shc/Grb2/Sos to the tyrosine phosphorylated PDGF-RL re-
sulting in an activation of the Raf/MAPKK and MAP kinase
pathway [13]. In the last years major attention has been fo-
cused on EGCG and little is known about the anticancer
activity of other green tea compounds. Furthermore, little is
known about the intracellular mechanisms explaining the anti-
cancer activity of the green tea compounds. The ability of the
cells to grow in an anchorage-independent fashion is consid-
ered to be the classic predictor of tumorigenicity [14]. There-
fore, we examined the e¡ect of EGCG, ECG, CG, catechin
and EC on the anchorage-independent growth of A172 cells in
semisolid agar [15]. Since autocrine activation of the PDGF-
RL seems to be the initial cause of the development of the
human A172 glioblastoma [16] we examined the e¡ect of the
di¡erent catechins on the PDGF-RL mediated intracellular
transduction pathway.
2. Materials and methods
2.1. Materials
Dulbecco’s modi¢ed Eagle’s medium (DMEM), Ham’s F-10 and
Dulbecco’s phosphate-bu¡ered saline (PBS) were obtained from Gib-
co BRL, Eggenstein, Germany. (3)-ECG, (3)-CG, (3)-EGCG, (3)-
EC catechin and Sepharose-coupled anti-phosphotyrosine antibody
were obtained from Sigma Chemical, Deisenhofen, Germany. Tyr-
phostin AG1296 was obtained from Calbiochem, Bad Soden, Ger-
many. PDGF-BB was prepared as described previously [17]. Mono-
clonal mouse anti-PI 3P-K, mouse anti-PLC-Q1, mouse antibodies were
obtained from Transduction Laboratories, Lexington, KY, USA. The
anti-PDGF-RL and anti-EGF rabbit polyclonal antibodies were ob-
tained from Santa Cruz (Heidelberg, Germany). The polyclonal anti-
CL100 antibody was a gift from Dr. Dirk Bokemeyer, Medizinische
Universita«ts-Poliklinik, Bonn, Germany. The horseradish peroxidase-
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labeled anti-rabbit and anti-mouse antibodies were obtained from
Amersham Life Sciences, Little Chalfont, UK.
2.2. Cell culture
A172 from human (male, 53 years old) were obtained from Interlab
Cell Line Collection, Genoa, Italy. Cells were cultured in DMEM
supplemented with 10% fetal calf serum (FCS), non-essential amino
acids, 100 IU/ml penicillin and 100 Wg/ml streptomycin at 37‡C in the
Steri-cult incubator from Forma Scienti¢c in a humidi¢ed atmosphere
of 95% air and 5% CO2.
2.3. Soft agar assay
The soft agar assay was performed as described previously [14].
Brie£y, 35 mm petri dishes were underlain with 1 ml MEM supple-
mented with 0.7% agar, 10% FCS and EGCG. After trypsinization,
5U104 A172 cells were suspended in 1.5 ml MEM supplemented with
0.35% agar, 10% FCS and 10 or 50 WM of catechins and plated on the
0.7% agar underlay. Cells were fed once per week with 2 ml MEM
supplemented with 10% FCS and 10 or 50 WM of catechins. Cells were
photographed by phase-contrast light microscope after 1 h and
3 weeks.
2.4. Gel electrophoresis and immunostaining
Con£uent cells in 75 cm2 were preincubated in serum-free medium
consisting of DMEM and Ham’s F-10 (1:1, v/v), in the presence and
absence of 50 WM of each catechin compound for 24 h. Then the
medium was replaced with serum-free medium without catechins
and A172 glioblastoma were stimulated with 50 ng/ml PDGF-BB.
After removing the medium cells were lysed with a 1 ml RIPA bu¡er
(50 mM NaCl, 20 mM Tris^HCl, 50 mM NaF, 10 mM EDTA, 20 mM
Na4P2O7W10H2O, 1% Triton X-100, pH 7.4) containing 1 mM
Na3VO4, 1 mM phenylmethylsulfonyl £uoride (PMSF), 10 Wg/ml leu-
peptin, 10 Wg/ml antipain, and 0.023 TIU/ml aprotinin. After 10 min
at 0‡C, cell lists were centrifuged at 14 000Ug for 2 min. Then super-
natant was mixed with 80 Wl Sepharose-coupled anti-phosphotyrosine
antibody and shaken for minimum 2 h at 4‡C. After elution of tyro-
sine phosphorylated proteins with 100 Wl of lysis bu¡er containing
5 mM phenylphosphate protein determination was performed using
the Bio-Rad DC Protein Assay. Proteins were separated in a 7.5%
SDS^polyacrylamide gel (SDS^PAGE). Proteins were transferred to a
PVDF membrane overnight at 100 mA with a bu¡er containing
25 mM Tris^HCl, 192 mM glycine and 20% methanol, pH 8.3. En-
hanced chemiluminescence Western blotting analysis was performed
with the chemiluminescence Western blotting system from NEN Life
Science Products, Inc. (Boston, MA, USA), using primary monoclo-
nal anti-PI 3P-K (1:5000), anti-PLC-Q1 (1:1000), or polyclonal anti-
PDGF-RL (1:500) IgGs. Chemiluminescence detection of PDGF-RL
was performed using secondary horseradish peroxidase-labeled anti-
rabbit IgG (1:5000). Detection of PI 3P-K, PLC-Q1 was performed
using secondary horseradish peroxidase-labeled anti-mouse IgG
(1:5000).
Immunoprecipitation and detection of mitogen-activated protein
kinase phosphatase-1 (MKP-1), the mouse homologue of CL100
(97% identity), were performed as we previously described [18].
Brie£y, con£uent cells in 10 cm (diameter) culture dishes were incu-
bated in serum-free medium consisting of a mixture of DMEM and
Ham’s F-10 medium (1:1) in the presence and absence of 50 WM
EGCG for 24 h. Cells were then stimulated with 50 ng/ml PDGF-
BB for 60 min. After removal of the medium, cells were lysed in 400 Wl
Triton X-100 lysis bu¡er containing 50 mM HEPES, pH 7.5, 150 mM
Fig. 1. E¡ect of PDGF-BB on tyrosine phosphorylation of PDGF-RL in A172 glioblastoma treated with 50 WM (3)-ECG, (3)-CG, (3)-
EGCG, (3)-EC, catechin, and Tyrphostin 1296. Con£uent cells in 75 cm2 were preincubated in serum-free medium consisting of DMEM in
the presence and absence of 50 WM of each catechin compound or 25 WM Tyrphostin 1296 for 24 h. Then the medium was replaced with se-
rum-free medium without catechins and A172 glioblastoma were stimulated with 50 ng/ml PDGF-BB for 5 min. Cell lysates were mixed with
80 Wl Sepharose-coupled anti-phosphotyrosine antibody to immunoprecipitate PDGF-RL. Tyrosine phosphorylated PDGF-RL was eluted with
lysis bu¡er containing 5 mM phenylphosphate. Tyrosine phosphorylated PDGF-RL (180 kDa) was detected by the enhanced chemiluminescence
Western blotting method using polyclonal rabbit anti-PDGF-RL IgG (1:500) and secondary horseradish peroxidase-labeled anti-rabbit IgG
(1:5000).
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NaCl, 1.5 mM MgCl2, 1 mM EGTA, 10% glycerol, 1% Triton X-100,
1 Wg/ml aprotinin, 1 Wg/ml leupeptin and 1 mM PMSF for 5 min at
4‡C. Lysates (500 Wg protein) were incubated for 2 h with 2 Wl poly-
clonal anti-CL100 antibody. Immunocomplexes were adsorbed to pro-
tein A-Sepharose and washed three times with lysis bu¡er. Proteins
were resolubilized by addition of an equal volume of 2Usample bu¡-
er. Then SDS^PAGE was performed using 4% and 10% acrylamide
for stacking and resolving gels, respectively. Protein was transferred to
nitrocellulose and probed with polyclonal antibodies against CL100.
Detection of the MKP-1 was performed using horseradish peroxidase-
conjugated protein A and the ECL chemiluminescence system from
Amersham.
3. Results and discussion
Treatment of A172 glioblastoma cells with CG, ECG,
EGCG at a concentration of 50 WM and with 25 WM Tyr-
phostin 1296 resulted in a remarkable inhibition of the
PDGF-BB-induced tyrosine phosphorylation of PDGF-RL
(Fig. 1A^C). CG, ECG and EGCG at a concentration of 50
WM as well as 25 WM Tyrphostin 1296 had no e¡ect on the
basal tyrosine phosphorylation of PDGF-RL. Laser densito-
metric analysis of the band densities of the tyrosine phosphor-
ylated PDGF-RL obtained by three separate experiments
showed that treatment of the A172 cells with 50 WM CG,
ECG, EGCG and 25 WM Tyrphostin 1296 resulted in a
82 þ 17%, 77 þ 21%, 75 þ 8% and 55 þ 11%, respectively,
(mean þ S.D., n = 3), inhibition of the PDGF-BB-induced ty-
rosine phosphorylation of the PDGF-RL in untreated cells
( = 100%). Catechin and EC had no e¡ect on the PDGF-
BB-induced tyrosine phosphorylation of PDGF-RL (Fig.
1D). Again, treatment of the cells with 50 WM EC or ECG
caused a remarkable decrease of the PDGF-BB-induced tyro-
sine phosphorylation of PDGF-RL (Fig. 1D). In order to
demonstrate that inhibition of the PDGF-BB-induced tyrosine
phosphorylation of PDGF-RL by e¡ective catechins also re-
sults in an inhibition of the downstream intracellular signal-
ling transduction pathway of PDGF-BB, parallel determina-
tion of the tyrosine phosphorylated PDGF-RL, PLC-Q1 and
PI 3P-K in CG-treated cells was performed. Again, as demon-
strated in Fig. 2, treatment of the cells with 50 WM CG re-
sulted in a marked decrease of the PDGF-BB-induced tyro-
sine phosphorylation of PDGF-RL, PLC-Q1 and PI 3P-K.
Results from three independent experiments demonstrated
that treatment of the cells with 1 to 20 WM CG, ECG and
EGCG had no statistically signi¢cant e¡ect on tyrosine phos-
phorylation of PDGF-RL, PLC-Q1 and PI 3P-K.
In order to demonstrate whether there is a correlation be-
tween the inhibitory e¡ect of CG, ECG, EGCG or Tyrphostin
1296 on tyrosine phosphorylation of PDGF-RL and the trans-
formation of A172 cells, spheroid formation of these cells in
soft agar in the presence and absence of CG, ECG, EGCG or
Tyrphostin 1296 was examined. Spheroid formation was al-
most completely inhibited by 50 WM ECG, CG and EGCG
and by 25 WM Tyrphostin 1296 (Fig. 3). CG, ECG and
EGCG at a concentration of 10 WM had no e¡ect on spheroid
formation (Fig. 3). Catechin and EC at a concentration of 50
WM had no e¡ect on spheroid formation (data not shown).
The present study gives evidence that not only EGCG but
also catechins that possess the gallate group (Fig. 4) are
able to suppress the tyrosine kinase activity of the PDGF-
RL. However, one may question whether concentrations of
green tea catechins are su⁄ciently high for inhibition of the
kinase activity of PDGF-RL. Green tea contains signi¢cant
amounts of catechins. Approximately 30^42% of the dry
weight of the green tea are catechins [19]. Furthermore, a
cup of green tea contains approximately 200 mg EGCG and
after drinking of two to three cups of tea the concentration of
EGCG in the plasma was 0.3 WM [4,7,20]. However, it is
possible that catechins are able to accumulate in tissues there-
by resulting in locally and temporally high concentrations of
catechins. Since EGCG and probably other catechins bind
strongly to many molecules and a¡ect a variety of enzyme
activities and signal transduction pathways at WM concentra-
tions [20] it can not be concluded that the anticancer activity
of the catechins is only related to the inhibition of the kinase
activity of PDGF-RL. Indeed, catechins may also exert anti-
cancer activities via inhibition of other kinases. On the other
hand it is well established that the PDGF-RL tyrosine kinase
of the A172 cells is chronically activated by endogenous
PDGF-BB [16]. Autocrine activation of the PDGF-RL seems
to be the initial cause of the development of A172 glioblasto-
ma [15,16]. In this context, we demonstrated that several cat-
echins prevented multicellular spheroid formation of human
A172 cells in semisolid agar. This ¢nding suggests that EGCG
Fig. 2. E¡ect of PDGF-BB on tyrosine phosphorylation of PDGF-
RL, PLC-Q1 and PI 3P-K in A172 glioblastoma treated with di¡erent
concentrations of (3)-CG. Con£uent cells in 75 cm2 were preincu-
bated in serum-free medium consisting of DMEM in the presence
and absence of di¡erent concentrations of (3)-CG for 24 h. Then
the medium was replaced with serum-free medium without (3)-CG
and A172 glioblastoma were stimulated with 50 ng/ml PDGF-BB
for 5 min. Cell lysates were mixed with 80 Wl Sepharose-coupled
anti-phosphotyrosine antibody to immunoprecipitate tyrosine
phosphorylated PDGF-RL (180 kDa), PLC-Q1 (150 kDa) and PI 3P-
K (85 kDa). Tyrosine phosphorylated proteins were detected by the
enhanced chemiluminescence Western blotting method using primary
polyclonal rabbit anti-PDGF-RL IgG (1:500), monoclonal anti-PI
3P-K (1:5000) and monoclonal anti-PLC-Q1 (1:1000) IgGs. Detection
of tyrosine phosphorylated PDGF-RL was performed using second-
ary horseradish peroxidase-labeled anti-rabbit IgG (1:5000). Detec-
tion of PI 3P-K and PLC-Q1 was performed using secondary horse-
radish peroxidase-labeled anti-mouse IgG (1:5000).
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might reduce cancer diseases in which activation of PDGF-RL
is causatively involved.
In order to explain the anticarcinogenic e¡ects of green tea
observed in several epidemiological studies [3] it has been also
postulated that EGCG acts as a scavenger of reactive oxygen
species (ROS) thereby preventing carcinogenesis [3,21]. It is
widely believed that ROS are involved in the initiation of
carcinogenesis. Besides the proposed mechanism that inhibi-
tion of tumor growth by green tea might be due to EGCG
mediated suppression angiogenesis [7] or due to the antioxi-
dant potency of EGCG protecting DNA from oxidative dam-
age, the mechanism we suggest might partly explain the anti-
cancer activity of several catechins found in green tea. Indeed,
consumption of green tea may act protectively against cancer
diseases by several mechanisms.
Enhanced activity of receptor tyrosine kinases including the
PDGF-RL, the EGF-R, VEGF-R has been implicated as a
contributing factor for the development of malignant prolif-
erative diseases such as cancer [10,22]. PDGF and its recep-
tors have been implicated in a number of cancer diseases in-
cluding gliomas [15], sarcomas [15], breast cancer [23], colon
cancer [24] and melanoma [25]. Therefore, in the last decade
tremendous e¡orts have been made to develop chemical syn-
thesized tyrosine kinase inhibitors as drug target for thera-
peutically treatment of cancer diseases [10,26]. In the present
study we demonstrate that several natural non-toxic com-
pounds isolated from green tea are also able to act as
PDGF-RL tyrosine kinase inhibitors thereby preventing spher-
oid formation of A172 glioblastoma cells. Therefore, we sug-
gest that these green tea compounds may be useful for treat-
ment of cancer diseases in which PDGF-BB and PDGF-RL
are involved [15,16]. Furthermore, chemical modi¢cation of
Fig. 3. Anchorage-independent growth of A172 glioblastoma cells in the presence and absence of the catechins. Petri dishes (35 mm) were
underlain with 1 ml modi¢ed Eagle’s medium (MEM) supplemented with 0.7% agar, 10% fetal calf serum (FCS) and catechins. After trypsini-
zation 5U104 A172 cells were suspended in 1.5 ml MEM supplemented with 0.35% agar, 10% FCS and 10 to 50 WM of each catechin com-
pound and plated on the 0.7% agar underlay. Representative ¢elds were photographed after 1 h and 3 weeks by phase-contrast light micro-
scope. Calibration bar represents 250 Wm.
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the chemical structure of the gallate group may result in much
more e¡ective compounds in inhibiting PDGF-related carci-
nogenesis. However, further clinical studies are necessary to
apply green tea compounds for treatment of cancer diseases.
The vaccine H-1 gene product (VH-1) was the ¢rst phos-
phatase shown to e¡ectively hydrolyze both phosphotyrosine
and phosphoserine/phosphothreonine [27]. The MKP-1 is a
mammalian VH-1-like dual speci¢city tyrosine phosphatase
[28]. The human homologue of MKP-1 is called CL100
(97% identity) [28]. Since it is possible that a decrease of the
tyrosine phosphorylation of the PDGF-RL could be due to an
enhanced phosphatase activity we examined the e¡ect of
EGCG on the MKP-1 formation in the A172 cells after stim-
ulation with 50 ng/ml PDGF-BB for 1 h. Furthermore, in
order to demonstrate whether catechins speci¢cally inhibit
the tyrosine phosphorylation of PDGF-RL we examined the
e¡ect of EGCG on the tyrosine phosphorylation of the EGF-
R after stimulation of the cells with 50 ng/ml EGF for 10 min
and immunoprecipitation of tyrosine phosphorylated EGF-R
using Sepharose-coupled anti-phosphotyrosine antibody. Pre-
treatment of the cells for 24 h with 50 WM EGCG had no
e¡ect on the PDGF-induced MKP-1 induction or on the
EGF-induced increase of the tyrosine phosphorylation of
the EGF-R in A172 cells (data not shown). These ¢ndings
are in good agreement with our previous ¢ndings demonstrat-
ing that EGCG had no e¡ects on the EGF-induced stimula-
tion of the extracellular signal-regulated kinases (ERK)1/2 in
vascular smooth muscle cells from rat aorta [8]. Furthermore,
we suggest that e¡ective catechins act via inhibition of the
kinase activity of PDGF-RL and not via increase of MKP-1.
Since it has been demonstrated that green tea and EGCG
inhibit VEGF-induced angiogenesis [7] we assume that EGCG
and other e¡ective consumption catechins may act via inhibi-
tion of the tyrosine phosphorylation of the VEGF receptors.
However, the question whether catechins inhibit tyrosine
phosphorylation of FGF or insulin receptors remain to be
elucidated.
In summary, we demonstrated that catechins of the green
tea possessing the gallate group in their chemical structure act
as anticancer agents probably partly via their ability to sup-
press the tyrosine kinase activity of the PDGF-RL. The
present ¢ndings may be helpful to explain the anticancer ac-
tivity of green tea observed in several epidemiological studies.
Finally, these ¢ndings may be important for development of
new prophylactic strategies for prevention of carcinogenesis in
the general human population.
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